Q4 2024 Waters Corp Earnings Call Transcript
Key Points
- Waters Corp (WAT) achieved high single-digit constant currency revenue growth and low-teens adjusted EPS growth in Q4 2024.
- Pharma sales, the largest end market for Waters Corp (WAT), grew in low double digits, indicating strong demand.
- Recurring revenues grew 9%, marking an improvement from the previous quarter, with chemistry and service both up high single digits.
- The Xevo TQ Absolute system, a key product, saw unit sales grow 40% year-over-year, contributing significantly to PFAS testing revenue growth.
- Waters Corp (WAT) achieved a 60 basis point increase in adjusted operating margin to 35.5%, despite FX headwinds.
- Sales for the full year were flat as reported and in organic constant currency terms, indicating challenges in overall growth.
- The US dollar's strengthening introduced significant foreign exchange headwinds, impacting financial performance.
- The Academic and Government segment saw a decline of 7% for the full year, reflecting challenges in this market.
- China sales, while returning to positive growth, only increased by low single digits, indicating a slow recovery.
- The company faces ongoing margin challenges, including FX, inflation, and normalization of annual incentive compensation.
Welcome to the Waters Cooperation fourth-quarter 2024 financial results conference call. (Operator Instructions) This call is being recorded. If you have any objections, please disconnect at this time.
It is now my pleasure to turn the call over to Mr. Caspar Tudor, Head of Investor Relations. Please go ahead, sir.
Thank you, Danny. Good morning, everyone, and welcome to the Waters Corporation fourth quarter earnings call. Today, I'm joined by Dr. Udi Batra, Waters President and Chief Executive Officer; and Amol Chaubal, Water's Senior Vice President and Chief Financial Officer.
Before we begin, I will cover the cautionary language. In this conference call, we'll make forward-looking statements regarding future events or future financial performance of the company. We will provide guidance regarding possible future results as well as commentary on potential market and business conditions that may impact Waters Corporation over the first quarter of 2025 and full-year 2025.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

